Form 4: iRhythm CFO Sells 5,000 Shares Under 10b5-1 Plan

iRhythm Technologies' Chief Financial Officer, Daniel G. Wilson, sold 5,000 shares of common stock for $175 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Daniel G. Wilson, Chief Financial Officer of iRhythm Technologies, Inc. (IRTC), disposed of 5,000 shares of common stock.
• The transaction occurred on September 3, 2025, with a deemed execution date also on September 3, 2025.
• The shares were sold at a price of $175 per share.
• This sale was conducted pursuant to a Rule 10b5-1 trading plan established by Mr. Wilson on November 14, 2024.
• Following this transaction, Mr. Wilson directly beneficially owns 34,470 shares of common stock.
• Additionally, Mr. Wilson indirectly owns 100 shares through The Wilson Living Trust dated July 9, 2015, where he serves as Trustee.

Sentiment

Score: 5

Explanation: A neutral score as the filing reports a factual, pre-planned insider stock sale. While insider sales can sometimes be viewed negatively, the 10b5-1 plan mitigates immediate concerns about new negative information. It's a routine disclosure.

Positives

• The sale was executed under a pre-established Rule 10b5-1 trading plan, indicating a planned transaction rather than an immediate reaction to new information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces management's direct equity stake in the company.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitors. It reflects an individual executive's portfolio management.

Comparison to Industry Standards

• This filing is a standard disclosure of an insider stock transaction, a common practice for executives to manage their equity holdings.
• The use of a Rule 10b5-1 trading plan aligns with common corporate governance practices designed to allow insiders to sell shares without concerns of trading on material non-public information, a practice widely adopted by executives across various industries.

Related Party Transactions

• Indirect ownership of 100 shares through The Wilson Living Trust dated July 9, 2015, where Mr. Wilson is the Trustee, represents a related party holding.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal, though the 10b5-1 plan suggests it is not based on new, adverse information. It slightly reduces the CFO's direct alignment with shareholder interests through equity ownership.
• Employees, customers, suppliers, and creditors are unlikely to experience a direct impact from this specific insider transaction report.

Key Dates

Recommendation

The filing details a pre-planned insider sale by the CFO under a Rule 10b5-1 plan. Such sales are typically for personal financial management and do not necessarily reflect a change in the executive's outlook on the company's prospects. Without additional information or context from other filings, this routine transaction alone does not warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

iRhythm Technologies, IRTC, Form 4, Insider Trading, Stock Sale, Daniel G. Wilson, CFO, 10b5-1 Plan, Beneficial Ownership